U of M Researcher Studies Immune Response to Influenza

MINNEAPOLIS, MN- October 23, 2019 – It is estimated that influenza (flu) results in 31.4 million outpatient visits each year. New research from the University of Minnesota Medical School provides insights into how the body can protect itself from immunopathology during flu.

“One of the reasons people feel bad during flu and some people die from flu isn’t actually the virus replication itself, but it is the immune system’s attempt to control the virus that causes that damage,” said lead author Ryan Langlois, PhD, assistant professor of Microbiology and Immunology at the Medical School. “That immune response, called immunopathology, is a very serious complication of flu.” 

Many people who get the flu recover in under two weeks because the immune system is able to clear the virus, leaving no trace of it in the body. Traditional theory thought this was accomplished by T cell-mediated killing of all infected cells. Several years ago, however, Langlois genetically engineered a flu virus that could permanently label infected cells, which led to the discovery that some infected cells do survive clearance.

The new study published in PLOS Pathogens examines why some infected cells evaded T cell-mediated killing in the lungs of a mouse model. Langlois and his team identified where the virus was in the lung and what types of cells it was in. They found that the formerly infected cells are able to clear the virus from the cell quick enough so that no remnants of the virus remained. Because T cells can’t kill what they can’t see, T cells need to see a virus in a cell to kill that cell.

After clearance, no virus exists in the lung, but the cells that used to be infected remain. The team found that those “survivor cells” actually divide and replenish themselves at a faster rate than uninfected cells.

“One can imagine that if T cells killed every infected cell, like people once thought they did, whole airways could be lost,” Langlois said. “This study lends more data to the idea that preventing immunopathology is incredibly important, and it allows us to better understand the basic mechanisms of how the body regulates itself to prevent it.”

Research reported in this publication was supported by the National Institutes of Health under Award Number R01AI132962. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About the University of Minnesota Medical School
The University of Minnesota Medical School is at the forefront of learning and discovery, transforming medical care and educating the next generation of physicians. Our graduates and faculty produce high-impact biomedical research and advance the practice of medicine. Visit med.umn.edu to learn how the University of Minnesota is innovating all aspects of medicine.

Contact: Kelly Glynn
Media Relations Coordinator, University of Minnesota Medical School
glynn040@umn.edu
612-301-3273

Share this post

Related News

  • Couple Returns to Minnesota, This Time to Make an Impact in Medicine

    Rahel Nardos, MD, MCR, and Damien Fair, PA-C, PhD, a married faculty duo are joining the University of Minnesota Medical School in different fields of medicine.Dr. Fair serves as the co-director of the Masonic Institute for the Developing Brain, and Dr. Nardos is an associate professor in the Department of Obstetrics, Gynecology and Women’s Health and serves as a urogynecologist and director for Global Women's Health at the Center for Global Health and Social Responsibility.

  • Long-standing ‘Hand Skills Day’ Simulation Goes Virtual

    With reduced exposure to the operating room during the COVID-19 pandemic, simulated orthopedic training has helped fill in learning gaps for residents, including the department’s James House, MD, Hand Skills Lectureship and Educational Workshop.